MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV)

Clinical trials for MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV) explained in plain language.

Never miss a new study

Get alerted when new MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV) trials appear

Sign up with your email to follow new studies for MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New MERS vaccine shows promise in human safety trial

⭐️ VACCINE ⭐️ Completed

This study tested an experimental vaccine called INO-4700 designed to protect against Middle East Respiratory Syndrome (MERS). Researchers enrolled 192 healthy volunteers to check if the vaccine was safe and if it triggered an immune response. The vaccine was given as a skin inje…

Matched conditions: MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV)

Phase: PHASE2 • Sponsor: Inovio Pharmaceuticals • Aim: ⭐️ VACCINE ⭐️

Last updated Mar 30, 2026 14:34 UTC

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV)

Get alerted when new MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV) trials appear

New MERS vaccine shows promise in human safety trial